Cargando…
Antihypertensive treatments in adult autosomal dominant polycystic kidney disease: network meta-analysis of the randomized controlled trials
BACKGROUND: Blood pressure (BP) control is one of the most important treatments of Autosomal dominant polycystic kidney disease (ADPKD). The comparative efficacy of antihypertensive treatments in ADPKD patients is inconclusive. METHODS: Network meta-analysis was used to evaluate randomized controlle...
Autores principales: | Xue, Cheng, Zhou, Chenchen, Dai, Bing, Yu, Shengqiang, Xu, Chenggang, Mao, Zhiguo, Ye, Chaoyang, Chen, Dongping, Zhao, Xuezhi, Wu, Jun, Chen, Wansheng, Mei, Changlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767449/ https://www.ncbi.nlm.nih.gov/pubmed/26636542 |
Ejemplares similares
-
Clinical Characteristics and Disease Predictors of a Large Chinese Cohort of Patients with Autosomal Dominant Polycystic Kidney Disease
por: Chen, Dongping, et al.
Publicado: (2014) -
Chromatin Methylation Abnormalities in Autosomal Dominant Polycystic Kidney Disease
por: Xu, Jing, et al.
Publicado: (2022) -
Complete staghorn calculus in polycystic kidney disease: infection is still the cause
por: Mao, Zhiguo, et al.
Publicado: (2013) -
New onset diabetes after kidney transplantation in patients with autosomal dominant polycystic kidney disease: systematic review protocol
por: Yang, Bo, et al.
Publicado: (2015) -
Fibroblast Growth Factor 23 Is a Valuable Predictor of Autosomal Dominant Polycystic Kidney Disease Progression
por: Xue, Cheng, et al.
Publicado: (2021)